BioNexus Gene Lab Corp (NASDAQ:BGLC) currently has a daily average trading volume of 103.18K but it saw 2331169 shares traded in last market. With a market cap of 6.45M USD, the company’s current market price of $0.36 came rising about 2.48 while comparing to the previous closing price of $0.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.39 and as low as $0.31. In the recent trading on the day, stock has struck highest price mark of $0.3401 while lowest mark touched by it was $0.4879.
Taking a look at 20-day trading activity of BioNexus Gene Lab Corp (BGLC) gives us an average price of $0.4203, while its current price level is -89.41% below from 52-week high level whereas it is 15.81% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4565 while that of 200 days or SMA-200 reads an average of $0.5799. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.12% during that period while stretching the period over a month that decreases to 11.48%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 32.46 which implies that the stock is in neutral territory.
Over the week, BGLC’s stock price is moving -17.01% down while it is -21.39% when we observe its performance for the past one month. Year-to-date it is -32.26% down and over the past year, the stock is showing a downside performance of -63.36%.
Currently, BioNexus Gene Lab Corp’s total number of outstanding shares is 17.67M. Company’s return on investment (ROI) stands at -22.67% and return on equity (ROE) at -28.44%. Stock’s beta reads 1.88. Stock has a price to book (P/B) ratio of 0.66 while price to sale or P/S ratio amounts to 0.70. Its return on asset (ROA) is -23.17% on average.
